Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-051802
Filing Date
2025-04-08
Accepted
2025-04-08 06:45:27
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-08

Document Format Files

Seq Description Document Type Size
1 ARS mreo_2024_ars.pdf ARS 2367568
  Complete submission text file 0000950170-25-051802.txt   3262590
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38452 | Film No.: 25820242
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)